Abstract Purpose of Review The population of HIV-exposed uninfected (HEU) children is
expanding rapidly, and over one million HEU infants are born each year globally. Several …

Objective: Previous studies have demonstrated that HIV-exposed uninfected (HEU) infants
and children experience morbidity and mortality at rates exceeding those of their HIV …

Background Children who are HIV-exposed uninfected (HEU) have higher morbidity and
mortality than children who are HIV-unexposed and uninfected despite safer breastfeeding …

Prior to widespread availability of antiretroviral therapy (ART) in sub-Saharan Africa,
children who were HIV-exposed but uninfected (HEU) had increased mortality, morbidity …

Objectives: Increased risk of morbidity and hospitalization has been observed in children
who are HIV-exposed uninfected (HEU) compared with HIV-unexposed uninfected (HUU) …

Background: HIV-exposed-uninfected (HEU) infants have increased infectious morbidity and
mortality; little is known about their levels of inflammation and monocyte activation. Methods …

Background Despite the recognized benefit of antiretroviral therapy (ART) for preventing and
treating HIV, some studies have reported adverse birth outcomes with in utero ART …

Introduction The population of 16 million children exposed to HIV and uninfected (CHEU)
under 15 years of age continues to expand rapidly, and the estimated prevalence of CHEU …

While preventing vertical HIV transmission has been very successful, HIV-exposed
uninfected infants (iHEU) experience an elevated risk to infections compared to HIV …

HIV-exposed uninfected (HEU) children may have altered immune regulation and poorer
neurodevelopment outcomes compared to their HIV-unexposed (HU) counterparts …